Sireesh Appajosyula insider trades: Hepion Pharmaceuticals (HEPA) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Sireesh reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | HEPA | ↑ Buy | 2,000,000 | $0.05 | $100K | Direct | Aug 12, 2026 (9d) |
| Jun 20, 2025 | THAR | ↑ Buy | 61,496 | $1.48 | $91K | Direct | Jun 23, 2025 (3d) |
| Nov 13, 2024 | THAR | ↑ Buy | 5,000 | $2.02 | $10K | Direct | Nov 13, 2024 (0d) |
| Oct 8, 2024 | THAR | ↑ Buy | 5,000 | $1.93 | $10K | Direct | Oct 8, 2024 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other HEPA insiders
Open-market trades in the last 12 months
About Sireesh Appajosyula's insider trades
Sireesh Appajosyula is Chief Executive Officer at Hepion Pharmaceuticals (HEPA). Since Oct 8, 2024, Sireesh has reported 4 open-market purchases worth $211K and no sales on SEC Form 4. In the last 12 months: 1 buy ($100K).
Their filings also include grants and awards (8 filings), other transactions (1 filing), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HEPA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.